1,2-dimethylhydrazine increases expression ISO RGD:1551725 6480464 1, 2-Dimethylhydrazine results in increased expression of H2-DMA mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of RT1-DMA mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression ISO RGD:1551725 6480464 Ethinyl Estradiol results in increased expression of H2-DMA mRNA CTD PMID:17942748 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1551725 6480464 2 more ... CTD PMID:21851831 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551725 6480464 Tetrachlorodibenzodioxin affects the expression of H2-DMA mRNA CTD PMID:21570461 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RT1-DMA mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1346716 6480464 Tetrachlorodibenzodioxin results in increased expression of HLA-DMA mRNA CTD PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1551725 6480464 Tetrachlorodibenzodioxin results in increased expression of H2-DMA mRNA CTD PMID:21041162 , PMID:21851831 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1551725 6480464 2 more ... CTD PMID:21851831 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1551725 6480464 Tetrachlorodibenzodioxin results in decreased expression of H2-DMA mRNA CTD PMID:28213091 2-butoxyethanol decreases expression ISO RGD:1551725 6480464 n-butoxyethanol results in decreased expression of H2-DMA mRNA CTD PMID:19812364 2-hydroxypropanoic acid decreases expression ISO RGD:1346716 6480464 Lactic Acid results in decreased expression of HLA-DMA mRNA CTD PMID:30851411 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of RT1-DMA mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1551725 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of H2-DMA exon CTD PMID:33297965 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1346716 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of HLA-DMA gene CTD PMID:31601247 4-hydroxyphenyl retinamide decreases expression ISO RGD:1551725 6480464 Fenretinide results in decreased expression of HLA-DMA mRNA CTD PMID:28973697 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO RGD:1346716 6480464 Omeprazole affects the expression of HLA-DMA mRNA CTD PMID:25811541 acrylamide decreases expression ISO RGD:1346716 6480464 Acrylamide results in decreased expression of HLA-DMA mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:1551725 6480464 Aflatoxin B1 results in increased expression of H2-DMA mRNA CTD PMID:19770486 alachlor increases expression EXP 6480464 alachlor results in increased expression of HLA-DMA mRNA CTD PMID:12419858 all-trans-retinoic acid increases expression ISO RGD:1551725 6480464 Tretinoin results in increased expression of H2-DMA mRNA CTD PMID:16604517 all-trans-retinoic acid increases expression ISO RGD:1346716 6480464 Tretinoin results in increased expression of HLA-DMA mRNA CTD PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of RT1-DMA mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1346716 6480464 Antirheumatic Agents results in decreased expression of HLA-DMA mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1346716 6480464 aristolochic acid I results in increased expression of HLA-DMA mRNA CTD PMID:33212167 arsane decreases response to substance ISO RGD:1346716 6480464 HLA-DMA mRNA results in decreased susceptibility to Arsenic CTD PMID:17976673 arsane decreases expression ISO RGD:1346716 6480464 Arsenic results in decreased expression of HLA-DMA mRNA CTD PMID:27838757 arsenic atom decreases response to substance ISO RGD:1346716 6480464 HLA-DMA mRNA results in decreased susceptibility to Arsenic CTD PMID:17976673 arsenic atom decreases expression ISO RGD:1346716 6480464 Arsenic results in decreased expression of HLA-DMA mRNA CTD PMID:27838757 atrazine increases expression ISO RGD:1346716 6480464 Atrazine results in increased expression of HLA-DMA mRNA CTD PMID:22378314 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of RT1-DMA gene CTD PMID:28931070 benzo[a]pyrene decreases expression ISO RGD:1551725 6480464 Benzo(a)pyrene results in decreased expression of H2-DMA mRNA CTD PMID:20713471 benzo[a]pyrene increases methylation ISO RGD:1346716 6480464 Benzo(a)pyrene results in increased methylation of HLA-DMA 3' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1346716 6480464 Benzo(a)pyrene affects the methylation of HLA-DMA exon, Benzo(a)pyrene affects the methylation of HLA-DMA promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I affects expression ISO RGD:1346716 6480464 7 more ... CTD PMID:20382639 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of HLA-DMA mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1551725 6480464 bisphenol A results in increased expression of H2-DMA mRNA CTD PMID:32156529 bisphenol A decreases methylation ISO RGD:1346716 6480464 bisphenol A results in decreased methylation of HLA-DMA gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1346716 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of HLA-DMA gene CTD PMID:31601247 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of RT1-DMA promoter CTD PMID:22457795 carbon nanotube affects expression ISO RGD:1551725 6480464 Nanotubes, Carbon analog affects the expression of H2-DMA mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1346716 6480464 Nanotubes more ... CTD PMID:25102311 carbon nanotube decreases expression ISO RGD:1551725 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 CGP 52608 multiple interactions ISO RGD:1346716 6480464 CGP 52608 promotes the reaction [RORA protein binds to HLA-DMA gene] CTD PMID:28238834 chloroprene decreases expression ISO RGD:1551725 6480464 Chloroprene results in decreased expression of H2-DMA mRNA CTD PMID:23125180 cisplatin multiple interactions ISO RGD:1346716 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of HLA-DMA mRNA, [Cisplatin co-treated with panobinostat] affects the expression of HLA-DMA mRNA CTD PMID:21791302 , PMID:27392435 cisplatin increases expression ISO RGD:1346716 6480464 Cisplatin results in increased expression of HLA-DMA mRNA CTD PMID:27392435 clobetasol increases expression ISO RGD:1551725 6480464 Clobetasol results in increased expression of H2-DMA mRNA CTD PMID:27462272 coumarin increases expression EXP 6480464 coumarin results in increased expression of HLA-DMA mRNA CTD PMID:18480146 cyclosporin A decreases expression ISO RGD:1346716 6480464 Cyclosporine results in decreased expression of HLA-DMA mRNA CTD PMID:20106945 , PMID:27989131 dexamethasone increases expression ISO RGD:1551725 6480464 Dexamethasone results in increased expression of H2-DMA mRNA CTD PMID:21041162 dexamethasone increases expression ISO RGD:1346716 6480464 Dexamethasone results in increased expression of HLA-DMA mRNA CTD PMID:25047013 dextran sulfate increases expression ISO RGD:1551725 6480464 Dextran Sulfate results in increased expression of H2-DMA mRNA CTD PMID:23894361 diethylstilbestrol increases expression ISO RGD:1551725 6480464 Diethylstilbestrol results in increased expression of H2-DMA mRNA CTD PMID:21041162 dorsomorphin multiple interactions ISO RGD:1346716 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1551725 6480464 Doxorubicin results in decreased expression of H2-DMA mRNA CTD PMID:28608983 entinostat multiple interactions ISO RGD:1346716 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HLA-DMA mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:1346716 6480464 entinostat results in increased expression of HLA-DMA mRNA CTD PMID:26272509 , PMID:27188386 epoxiconazole decreases expression ISO RGD:1551725 6480464 epoxiconazole results in decreased expression of H2-DMA mRNA CTD PMID:35436446 fonofos increases methylation ISO RGD:1346716 6480464 Fonofos results in increased methylation of HLA-DMA promoter CTD PMID:22847954 fulvestrant multiple interactions ISO RGD:1346716 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of HLA-DMA gene CTD PMID:31601247 genistein increases expression ISO RGD:1551725 6480464 Genistein results in increased expression of H2-DMA mRNA CTD PMID:32186404 hexachlorobenzene decreases expression EXP 6480464 Hexachlorobenzene results in decreased expression of HLA-DMA mRNA CTD PMID:15159207 isoprenaline decreases expression ISO RGD:1551725 6480464 Isoproterenol results in decreased expression of H2-DMA mRNA CTD PMID:20003209 lead(0) decreases expression ISO RGD:1346716 6480464 Lead results in decreased expression of HLA-DMA mRNA CTD PMID:19921347 lead(2+) decreases expression ISO RGD:1346716 6480464 Lead results in decreased expression of HLA-DMA mRNA CTD PMID:19921347 mercury dibromide multiple interactions ISO RGD:1346716 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HLA-DMA mRNA CTD PMID:27188386 methyl methanesulfonate decreases expression ISO RGD:1346716 6480464 Methyl Methanesulfonate results in decreased expression of HLA-DMA mRNA CTD PMID:23649840 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of HLA-DMA mRNA CTD PMID:19638242 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of RT1-DMA mRNA CTD PMID:25380136 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of RT1-DMA mRNA CTD PMID:19716841 nickel sulfate decreases expression ISO RGD:1346716 6480464 nickel sulfate results in decreased expression of HLA-DMA mRNA CTD PMID:16780908 omeprazole affects expression ISO RGD:1346716 6480464 Omeprazole affects the expression of HLA-DMA mRNA CTD PMID:25811541 ozone decreases expression ISO RGD:1551725 6480464 Ozone results in decreased expression of H2-DMA mRNA CTD PMID:12763052 panobinostat multiple interactions ISO RGD:1346716 6480464 [Cisplatin co-treated with Panobinostat] affects the expression of HLA-DMA mRNA more ... CTD PMID:21791302 , PMID:27188386 panobinostat increases expression ISO RGD:1346716 6480464 panobinostat results in increased expression of HLA-DMA mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:1346716 6480464 Acetaminophen affects the expression of HLA-DMA mRNA CTD PMID:25811541 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of RT1-DMA mRNA CTD PMID:33387578 parathion increases methylation ISO RGD:1346716 6480464 Parathion results in increased methylation of HLA-DMA promoter CTD PMID:22847954 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of HLA-DMA mRNA CTD PMID:19162173 pirinixic acid decreases expression ISO RGD:1551725 6480464 pirinixic acid results in decreased expression of H2-DMA mRNA CTD PMID:17426115 pirinixic acid increases expression ISO RGD:1551725 6480464 pirinixic acid results in increased expression of H2-DMA mRNA CTD PMID:18301758 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of HLA-DMA mRNA, pirinixic acid results in decreased expression of RT1-DMA mRNA CTD PMID:19162173 , PMID:21318169 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of HLA-DMA mRNA CTD PMID:19162173 quercetin increases expression ISO RGD:1551725 6480464 Quercetin results in increased expression of H2-DMA mRNA, Quercetin results in increased expression of HLA-DMA mRNA CTD PMID:16455785 , PMID:25862958 quercetin increases expression ISO RGD:1346716 6480464 Quercetin results in increased expression of HLA-DMA mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO RGD:1346716 6480464 Lactic Acid results in decreased expression of HLA-DMA mRNA CTD PMID:30851411 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of RT1-DMA mRNA CTD PMID:25905778 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of RT1-DMA mRNA CTD PMID:25905778 rifampicin increases expression ISO RGD:1346716 6480464 Rifampin results in increased expression of HLA-DMA mRNA CTD PMID:24552687 SB 431542 multiple interactions ISO RGD:1346716 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of RT1-DMA mRNA CTD PMID:22431001 silicon dioxide decreases expression ISO RGD:1346716 6480464 Silicon Dioxide analog results in decreased expression of HLA-DMA mRNA CTD PMID:25895662 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of RT1-DMA mRNA CTD PMID:16414398 sodium arsenite multiple interactions ISO RGD:1346716 6480464 sodium arsenite results in decreased expression of and affects the splicing of HLA-DMA mRNA CTD PMID:25879800 sodium dichromate decreases expression ISO RGD:1346716 6480464 sodium bichromate results in decreased expression of HLA-DMA mRNA CTD PMID:17685462 Soman increases expression EXP 6480464 Soman results in increased expression of HLA-DMA mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of RT1-DMA mRNA CTD PMID:25905778 sulforaphane decreases expression ISO RGD:1346716 6480464 sulforaphane results in decreased expression of HLA-DMA mRNA CTD PMID:26833863 tamibarotene increases expression ISO RGD:1346716 6480464 tamibarotene results in increased expression of HLA-DMA mRNA CTD PMID:17229644 temozolomide decreases expression ISO RGD:1346716 6480464 Temozolomide results in decreased expression of HLA-DMA mRNA CTD PMID:31758290 terbufos increases methylation ISO RGD:1346716 6480464 terbufos results in increased methylation of HLA-DMA promoter CTD PMID:22847954 thapsigargin increases expression ISO RGD:1346716 6480464 Thapsigargin results in increased expression of HLA-DMA mRNA CTD PMID:22378314 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of RT1-DMA mRNA CTD PMID:23411599 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of RT1-DMA mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1551725 6480464 titanium dioxide results in increased expression of H2-DMA mRNA CTD PMID:23557971 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of RT1-DMA mRNA CTD PMID:33387578 trichostatin A multiple interactions ISO RGD:1346716 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HLA-DMA mRNA CTD PMID:27188386 trichostatin A increases expression ISO RGD:1346716 6480464 trichostatin A results in increased expression of HLA-DMA mRNA CTD PMID:26272509 , PMID:26705709 Triptolide increases expression ISO RGD:1551725 6480464 triptolide results in increased expression of H2-DMA mRNA CTD PMID:32835833 triptonide increases expression ISO RGD:1551725 6480464 triptonide results in increased expression of H2-DMA mRNA CTD PMID:33045310 tunicamycin increases expression ISO RGD:1346716 6480464 Tunicamycin results in increased expression of HLA-DMA mRNA CTD PMID:22378314 valdecoxib affects expression ISO RGD:1346716 6480464 valdecoxib affects the expression of HLA-DMA mRNA CTD PMID:25811541 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of HLA-DMA mRNA, Valproic Acid results in increased expression of RT1-DMA mRNA CTD PMID:21318169 valproic acid increases expression ISO RGD:1346716 6480464 Valproic Acid results in increased expression of HLA-DMA mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1346716 6480464 Valproic Acid affects the expression of HLA-DMA mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1346716 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HLA-DMA mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1551725 6480464 Valproic Acid results in increased expression of H2-DMA mRNA CTD PMID:21427059 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of RT1-DMA mRNA CTD PMID:22570695 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of RT1-DMA mRNA CTD PMID:23034163 vorinostat multiple interactions ISO RGD:1346716 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HLA-DMA mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1346716 6480464 vorinostat results in increased expression of HLA-DMA mRNA CTD PMID:26272509 zoledronic acid increases expression ISO RGD:1346716 6480464 zoledronic acid results in increased expression of HLA-DMA mRNA CTD PMID:24714768
